Tag Archives: Biogen

Novartis sues Medimmune, Biogen and Alexion

[Bloomberg] Novartis sues Medimmune (subsidiary of astrazeneca), Biogen and Alexion pharmaceuticals on US patent 5688688. The target products are AstraZeneca’s Synagisrespiratory treatment; Biogen’s Tysabri for multiple sclerosis; and Alexion’s Soliris, used to treat a life-threatening form of anemia View complaint on prior smart Filed on … Continue reading

Posted in Patent case | Tagged , , , , , , , | Leave a comment